Barclays Issues Positive Forecast for Omada Health (NASDAQ:OMDA) Stock Price

Omada Health (NASDAQ:OMDA) had its price target boosted by Barclays from $28.00 to $29.00 in a research report released on Friday,Benzinga reports. The firm currently has an overweight rating on the stock.

Other equities research analysts have also recently issued research reports about the company. Robert W. Baird initiated coverage on Omada Health in a report on Friday, September 5th. They issued a “neutral” rating and a $24.00 target price for the company. Baird R W raised shares of Omada Health to a “hold” rating in a research report on Friday, September 5th. Weiss Ratings reiterated a “sell (d)” rating on shares of Omada Health in a research report on Wednesday, October 8th. Canaccord Genuity Group increased their target price on shares of Omada Health from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Finally, Needham & Company LLC lifted their price target on shares of Omada Health from $26.00 to $28.00 and gave the company a “buy” rating in a research note on Friday. Seven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $26.25.

Omada Health Trading Down 7.1%

OMDA traded down $1.56 during trading on Friday, reaching $20.31. 1,749,606 shares of the stock traded hands, compared to its average volume of 439,663. The company has a 50-day simple moving average of $23.70. Omada Health has a 12 month low of $14.14 and a 12 month high of $28.40.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.07). The firm had revenue of $61.37 million during the quarter, compared to analysts’ expectations of $55.17 million.

Institutional Trading of Omada Health

Hedge funds and other institutional investors have recently bought and sold shares of the business. Sanofi bought a new position in shares of Omada Health in the second quarter valued at $9,606,000. Teacher Retirement System of Texas bought a new stake in shares of Omada Health during the second quarter worth about $640,000. Jennison Associates LLC acquired a new stake in shares of Omada Health in the 2nd quarter worth about $4,580,000. Emerald Advisers LLC bought a new position in Omada Health in the 2nd quarter valued at about $5,089,000. Finally, Emerald Mutual Fund Advisers Trust acquired a new position in Omada Health during the 2nd quarter valued at about $2,950,000.

About Omada Health

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.